BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen X, Kong S, Yang Q, Yin Q, Cong H, Wang X, Ju S. PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7/NF-κB pathway in multiple myeloma. J Cell Mol Med 2020;24:3492-503. [PMID: 32048803 DOI: 10.1111/jcmm.15035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghafouri-Fard S, Abak A, Fattahi F, Hussen BM, Bahroudi Z, Shoorei H, Taheri M. The interaction between miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders. Biomed Pharmacother 2021;138:111519. [PMID: 33756159 DOI: 10.1016/j.biopha.2021.111519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Carrasco-León A, Amundarain A, Gómez-Echarte N, Prósper F, Agirre X. The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma. Cancers (Basel) 2021;13:1976. [PMID: 33923983 DOI: 10.3390/cancers13081976] [Reference Citation Analysis]
3 Zhao P, Zhao X. Baseline lncRNA PCAT1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients. J Clin Lab Anal 2021;35:e23924. [PMID: 34564896 DOI: 10.1002/jcla.23924] [Reference Citation Analysis]
4 Che F, Chen J, Wan C, Huang X. MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis. Front Oncol 2020;10:571914. [PMID: 33262943 DOI: 10.3389/fonc.2020.571914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Chen D, Yang X, Liu M, Zhang Z, Xing E. Roles of miRNA dysregulation in the pathogenesis of multiple myeloma. Cancer Gene Ther 2021. [PMID: 33402729 DOI: 10.1038/s41417-020-00291-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ghafouri-Fard S, Dashti S, Taheri M. PCAT1: An oncogenic lncRNA in diverse cancers and a putative therapeutic target. Exp Mol Pathol 2020;114:104429. [PMID: 32220602 DOI: 10.1016/j.yexmp.2020.104429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shen X, Kong S, Yang Q, Yin Q, Cong H, Wang X, Ju S. PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7/NF-κB pathway in multiple myeloma. J Cell Mol Med 2020;24:3492-503. [PMID: 32048803 DOI: 10.1111/jcmm.15035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
8 Soliman AM, Das S, Teoh SL. Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis. Int J Mol Sci 2021;22:7470. [PMID: 34299097 DOI: 10.3390/ijms22147470] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wang Y, Lin Q, Song C, Ma R, Li X. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis. Cell Cycle 2020;19:3289-302. [PMID: 33131409 DOI: 10.1080/15384101.2020.1839701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wang F, Luo Y, Zhang L, Younis M, Yuan L. The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway. Cancer Gene Ther 2021. [PMID: 33707625 DOI: 10.1038/s41417-021-00309-5] [Reference Citation Analysis]
11 Rivera HM, Muñoz EN, Osuna D, Florez M, Carvajal M, Gómez LA. Reciprocal Changes in miRNA Expression with Pigmentation and Decreased Proliferation Induced in Mouse B16F1 Melanoma Cells by L-Tyrosine and 5-Bromo-2'-Deoxyuridine. Int J Mol Sci 2021;22:1591. [PMID: 33562431 DOI: 10.3390/ijms22041591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]